Login
$HUMA
$0.45 +$0.05 (11.41%) Close

Ownership

13F as of Q2 2026 · 277.8M shares outstanding

Who owns HUMA?

By type of holder
Institutions 25.8% Insiders 2.1% Everyone else 72.1%
Concentration Top 10 holders own 25.2%
Fresenius Medical Care Holdings, Inc. 4.9% · Fresenius Medical Care AG 4.9%
Institutional ownership
25.8%
+4.6 pts vs last qtr
Institutional holders
163
+4 vs last qtr
Net shares bought
+12.6M
by institutions in Q2 2026
New / sold out
40 / 36
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Alyeska Investment Group, L.P. NEW +6.0M
  • Davidson Kempner Capital Management LP NEW +5.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BlackRock, Inc. −7.5M
  • State Street Corp −2.2M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$82.3K
2 notices from 2 people
Shares covered
91.8K
0.03% of the company
Arranged in advance
100%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$41.1K$82.3KNovDecJanFebMarAprMay 2026: $82.3K under a 10b5-1 planMayJunJulAugSepOct
Largest proposed sellers
  • Parikh Shamik J Officer 10b5-1 $41.1K
  • Sander Dale A. Officer 10b5-1 $41.1K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+2643.1%
+93.93% a year
Each share's claim on the business
−96.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $43.7M
over 6 fiscal years
Diluted shares, split-adjusted
5.6M82.7M159.7M2020: 5.8M shares'202021: 40.0M shares'212022: 103.1M shares'222023: 103.4M shares'232024: 118.5M shares'242025: 158.2M shares'25
Buybacks Stock-based comp
$0$5.1M$10.1M2020 buybacks: $02020 stock comp: $4.7M'202021 buybacks: $02021 stock comp: $10.1M'212022 buybacks: $02022 stock comp: $6.2M'222023 buybacks: $02023 stock comp: $6.8M'232024 buybacks: $02024 stock comp: $6.1M'242025 buybacks: $02025 stock comp: $9.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years1% 3–5 years39% 1–3 years26% Under 1 year34%
Quarterly turnover
41.9%
of institutional shares changed hands
Top 10 managers, median time held
2.8 years

Super Investors

Investment managers reporting HUMA on Form 13F
B
BlackRock, Inc.
Shares
4.8M
% of company
1.74%
Change vs last qtr
−7.5M (−60.7%)
Held since
2021
VC
Vanguard Capital Management LLC
Shares
10.1M
% of company
3.64%
Change vs last qtr
+2.9M (+41.2%)
Held since
2021

28 more super investors behind a free account

See every manager holding Humacyte Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting HUMA on Form N-PORT; together they hold 9.7% of the company
VT
Position value
$6.02M
% of company
2.78%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$2.34M
% of company
1.39%
% of the fund
0.00%
As of
March 31, 2026

23 more funds behind a free account

See every fund holding Humacyte Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FM
Fresenius Medical Care Holdings, Inc.
5%+ holder13D · 4.9%
Shares
13.6M
% of company
4.90%
Change vs last qtr
—
Held since
—
FM
Fresenius Medical Care AG
5%+ holder13D · 4.9%
Shares
13.6M
% of company
4.90%
Change vs last qtr
—
Held since
—

10 more holders behind a free account

See every insider and 5%+ holder of Humacyte Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support